Medication Overuse Headaches

Medical Clinics of North America

Volumn 97, Issue 2, 2013, Pages 337-352

  Abrams, Bernard M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic daily headaches; Combination analgesics; Detoxification; Ergots; Medication overuse headache; Opioids; Prophylactic medications; Triptans

Indexed keywords

ACETYLSALICYLIC ACID; ERGOTAMINE; PREDNISONE; TOPIRAMATE; TRIPTAN DERIVATIVE;

ADULT; ANXIETY; CASE REPORT; CHRONIC DAILY HEADACHE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; FEMALE; FOLLOW UP; HUMAN; MIGRAINE WITHOUT AURA; NECK PAIN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIMARY HEADACHE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECONDARY HEADACHE;

ANALGESICS; DIAGNOSIS, DIFFERENTIAL; ERGOT ALKALOIDS; HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; MIGRAINE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TRYPTAMINES;

EID: 84873923287     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.12.007     Document Type: Review

References (59)

1. Diener H.C., Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475-483.
2. Headache Classification Committee of the International Headache Society The international classification of headache disorders. Cephalalgia 2004, 24(Suppl 1):1-160.
3. Olesen J., Lipton R.B. Headache classification update 2004. Curr Opin Neurol 2004, 17:275-282.
4. Olesen J., Bousser M.G., Diener H.C., et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742-746.
5. Horton B.T., Peters G.A. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963, 3:214-226.
6. Peters G.A., Horton B.T. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 1951, 26:153-161.
7. Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstandings. Drug-induced headache 1988, 87-93. Springer-Verlag Berlin Heidelberg, New York, London, Paris, Tokyo. H.C. Diener, M. Wildinson (Eds.).
8. Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 1988, 8:1-96.
9. Silberstein S.D., Lipton R.B., Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871-875.
10. Diener H.C., Silberstein S. Medication overuse headache. The headaches 2006, 475-483. Lippincott Williams Wilkins, Philadelphia. J. Olesen, P.J. Goadsby, N. Ramadan (Eds.).
11. Lenaerts M.E., Couch J.R. Medication overuse headache. Minerva Med 2007, 98:221-231.
12. Negro A., Martelletti P. Chronic migraine plus medication overuse headache: two entities or not?. J Headache Pain 2011, 12:593-601.
13. Couch J.R., Lenaerts M.E. Medication overuse headache: clinical features, pathogenesis and management. Drug Dev Res 2007, 68:1-12.
14. Olesen J., Bousser M.G., Diener H., et al. The international classification of headache disorders, 2nd edn. Cephalalgia 2004, 24(Suppl 1):1-160.
15. Rapoport A., Weeks R., Sheftell F. Analgesic rebound headache: theoretical and practical implications. Proceedings second international headache congress 1985, 448-449. Kopenhagen, Copenhagen (Denmark). J. Olesen, P. Tfelt-Hansen, K. Jensen (Eds.).
16. Limmroth V., Kazarawa S., Fritsche G., et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002, 59:1011-1014.
17. Tepper S.J., Tepper D.E. Breaking the cycle of medication overuse headache. Cleve Clin J Med 2010, 77:236-242.
18. Bigal M.E., Serrano D., Buse D., et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population based study. Headache 2008, 48:1157-1168.
19. Diener H.C., Dahlof C.G. Headache associated with chronic use of substances. The headaches 1999, 871-878. Lippincott, Williams & Wilkins, Philadelphia. 2nd edition. J. Olesen, P. Tfelt-Hansen, K.M. Welch (Eds.).
20. Zeeberg P., Olesen J., Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006, 66:1894-1898.
21. Diener H.C. How to treat medication overuse headache prednisolone or no prednisolone?. Neurology 2007, 69:14-15. [editorials].
22. Scher A.I., Stewart W.F., Ricci J.A., et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81-89.
23. Katsarava Z., Schneeweiss S., Kurth T., et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004, 62:788-790.
24. Bahra A., Walsh M., Menon S., et al. Does chronic daily headache arise de novo in association with regular analgesic use?. Headache 2003, 43:179-190.
25. Lance F., Parkes C., Wilkinson M. Does analgesic abuse cause headache de novo?. Headache 1988, 38:61-62.
26. Mehlsteibel D., Schankin C., Hering P., et al. Anxiety disorders in headache patient's in a specialised clinic: prevalence and symptoms in comparison to patients in a general neurological clinic. J Headache Pain 2011, 12:323-329.
27. Reuter U., Salomone S., Ickstein G.W., et al. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HAT receptor expression and function in rats. Cephalalgia 2004, 24:398-407.
28. Dobson C.F., Tohyama Y., Diksic M., et al. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004, 24:2-11.
29. Tohyama Y., Yamane F., Fikre Merid M., et al. Effects of serotonin receptor agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J Neurochem 2002, 80:788-798.
30. Srikiatkhachorn A., Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 1996, 16(6):423-426.
31. Srikiatkhachorn A., Tarasub N., Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40(5):343-350.
32. de Tommaso M., Libro G., Guido M., et al. Heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in chronic tension-type headache. Pain 2003, 104:111-119.
33. Schmidt-Wilcke T., Leinisch E., Straube A., et al. Gray matter decrease in patients with chronic tension type headache. Neurology 2005, 65:1483-1486.
34. Fumal A., Laureys S., Di Clemente L., et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006, 129:543-550.
35. Ferraro S., Grazzi L., Mandelli M.L., et al. Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med 2012, 13(2):255-262.
36. Diaz-Mitoma F., Vanast W.J., Tyrrell D.L. Increased frequency of Epstein-Barr-virus excretion in patients with new daily persistent headaches. Lancet 1987, 1(8530):411-414.
37. Baumgartner C., Wessely P., Bingol C., et al. Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989, 29:510-514.
38. Boe M.G., Mygland A., Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007, 69(1):26-31.
39. Diener H.C., Dichgans J., Scholz E., et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989, 236:9-14.
40. Grazzi L., Andrasik F., D'Amico D., et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002, 42:483-490.
41. Evers S., Suhr B., Bauer B., et al. A retrospective long-term analysis of the epidemiology and features of drug-induced headache. Neurology 1999, 246(9):802-809.
42. Fritsche G., Frettloöh J., Hüppe M., et al. Prevention of medication overuse in patients with migraine. Pain 2010, 15(2):404-413.
43. Pini L.A., Cicero A.F., Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21(9):878-883.
44. Schnider P., Aull S., Baumgartner C., et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996, 16:481-485.
45. Tribl G.G., Schnider P., Wober C., et al. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache?. Cephalalgia 2001, 21(6):691-696.
46. Zidverc-Trajkovic J., Pekmezovic T., Jovanovic Z., et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007, 27(11):1219-1225.
47. Grazzi L., Andrasik F., Usai S., et al. In-patient versus day- hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results one year followup. Neurol Sci 2008, 29:161-163.
48. Diener H.C., Evers S., Fritsche G., et al. Medication overuse headache. Guidelines of the german society of neurology 2009, Thieme Verlag. H.C. Diener (Ed.).
49. Gaul C., van Doorn C., Webering N., et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain 2011, 12:475-483.
50. Gaul C., Visscher C.M., Bhola R., et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain 2011, 12:511-519.
51. Pageler L., Katsarava Z., Diener H.C., et al. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 2008, 28(2):152-156.
52. Lipton R.B., Bigal M.E., Diamond M., et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007, 68:343-349.
53. Antonaci F., Dumitrache C., De Cillis I., et al. A review of current European guidelines for migraine. J Headache Pain 2010, 11:13-19.
54. Diener H.C., Bussone G., Van Oene J.C., TOPMAT-MIG-201(TOP-CHROME) Study Group, et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007, 27:814-823.
55. Silberstein S.D., Lipton R.B., Dodick D.W., Group Topiramate Chronic Migraine Study, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007, 47:170-180.
56. Silberstein S.D., Neto W., Schmitt J., MIGR-001 Study Group, et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004, 61:490-495.
57. Dodick D.W., Turkel C.C., DeGryse R.E., PREEMPT Chronic Migraine Study Group, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized placebo-controlled phases of the PREEMPT clinical program. Headache 2010, 50:921-936.
58. Aurora S.K., Dodick D.W., Turkel C.C., PREEMPT 1 Chronic Migraine Study Group, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010, 30:793-803.
59. Diener H.C., Dodick D.W., Aurora S.K., PREEMPT 2 Chronic Migraine Study Group, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010, 30:804-814.